Study of KN046 in Subjects With Advanced Non-Small Cell Lung Cancer
Clinical trial NCT05420220 · COMPLETED
Trial details
- NCT number
- NCT05420220
- Sponsor
- Jiangsu Alphamab Biopharmaceuticals Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-26
- Primary completion
- 2024-12-31
- Enrollment
- 95
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.